News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Sequencing HF Meds? Most Doctors Stick to Old Habits, Survey Says Todd Neale December 08, 2022
News Conference News AHA 2022 Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions Yael L. Maxwell November 01, 2022
News Conference News EACTS 2022 CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration? Shelley Wood October 12, 2022
News Conference News HFSA 2022 New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented Todd Neale October 07, 2022
News Daily News Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use L.A. McKeown October 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News HFSA 2022 Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER Todd Neale October 04, 2022
Presentation TCT 2022 A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling) Presenter: Gregg W. Stone September 19, 2022
Presentation TCT 2022 Transcatheter Pulmonary Artery Banding for Patients With HFrEF (Restore Medical) Presenter: Gilad Marom September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News ESC 2022 DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum Todd Neale August 27, 2022
News Conference News ESC 2022 Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR L.A. McKeown August 27, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ESC 2022 No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE Shelley Wood August 26, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Daily News Quadruple Therapy Costs Prohibitive for Many HFrEF Patients L.A. McKeown June 21, 2022
Presentation TVT 2022 Less Invasive Ventricular Enhancement for HFrEF Presenter: John Boehmer June 10, 2022
Presentation TVT 2022 Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment Presenter: Chetan Huded June 10, 2022